Strategic Partnerships Leverage AccuraGen's liquid biopsy focus and large gene panels to pursue co development and licensing opportunities with pharma for companion diagnostics, while engaging hospitals for adoption of screening and precision medicine programs across markets.

Global Reach With a cross border presence in the US and China, target global diagnostics firms, CROs, and distributors to scale pipeline diagnostics, accelerate market entry, and tailor offerings to local regulatory landscapes.

Data Services Offer end to end data enabled services including sequencing data generation, processing, storage, and analytics for research labs and biotech companies, creating a recurring revenue stream and platform based partnerships.

Early Detection Position the Accu Scan Panel and liquid biopsy capabilities as an early detection solution for high impact cancers, targeting hospitals and payer networks screening initiatives and clinical trial screening programs.

Security and Compliance Highlight robust cloud infrastructure and security practices to appeal to HIPAA and GDPR regulated entities, healthcare networks, and CROs seeking compliant data workflows and trusted data management.